Greater Cannabis Company (GCAN) Operating Margin Growth (3y) (2020 - 2021)

Greater Cannabis Company (GCAN) Operating Margin Growth (3y) (2020 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Haleon 89.51 Bn 87.64 Bn - -
2 Teva Pharmaceutical Industries 36.00 Bn 32.26 Bn 1.97 Bn 1,673.00
3 Zoetis 32.61 Bn 30.67 Bn 1.62 Bn -37.00
4 Takeda Pharmaceutical 27.49 Bn 23.43 Bn 4.39 Bn -5,395.00
5 United Therapeutics 23.05 Bn 20.90 Bn 648.10 Mn -1,442.00
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.26 Bn 18.46 Bn 1.16 Bn -1,299.00
8 Neurocrine Biosciences 17.79 Bn 16.47 Bn 800.70 Mn 5,091.00
9 Elanco Animal Health 12.64 Bn 12.21 Bn 785.00 Mn 5,193.00
10 Greater Cannabis Company 236,233.75 234,794.75 - -

Historic Data

Download Data
DateValue
Jun 30, 2021 -59,398.00
Jun 30, 2020 4.35 Mn